Form 4: BDX CFO's Tax Withholding on RSU Vesting

Becton Dickinson's EVP & CFO, Christopher DelOrefice, reported the withholding of 278 common shares for tax obligations related to restricted stock unit vesting.

Summary

• Christopher DelOrefice, Executive Vice President and Chief Financial Officer of Becton Dickinson & Co (BDX), reported a transaction on September 1, 2025.
• The transaction involved the disposition of 278 shares of BDX Common Stock.
• These shares were withheld for the payment of withholding taxes in connection with the vesting of previously reported restricted stock units.
• Following this transaction, DelOrefice beneficially owns 21,221 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: Neutral. This is a routine, non-discretionary transaction related to executive compensation and tax obligations, not indicative of a change in sentiment towards the company or its operational performance.

Positives

• The transaction represents the vesting of restricted stock units, indicating the executive's continued equity participation and alignment with shareholder interests.
• The disposition of shares was for tax withholding purposes, not a discretionary sale by the executive.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it primarily reports a past (or pre-scheduled future) insider transaction.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically a tax withholding event related to executive equity compensation. Such transactions are common across all industries for publicly traded companies that utilize restricted stock units or similar equity awards as part of their executive compensation packages. It does not provide specific insights into broader industry trends for the medical technology sector.

Comparison to Industry Standards

• The withholding of shares for tax purposes upon the vesting of restricted stock units is a standard and widely accepted practice for executive compensation across public companies, including those in the medical technology industry like Becton Dickinson & Co.
• This type of transaction is a common mechanism for executives to cover tax liabilities arising from equity awards, similar to practices observed at peer companies such as Medtronic (MDT) or Abbott Laboratories (ABT) when their executives' equity awards vest.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine tax withholding, not a discretionary sale. It reflects the ongoing structure of executive compensation.
• Employees: No direct impact on the broader employee base.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary transaction where shares were withheld for tax purposes upon the vesting of restricted stock units. It does not provide new information that would alter the fundamental investment thesis for Becton Dickinson & Co, hence a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Becton Dickinson, BDX, Form 4, Insider Transaction, Christopher DelOrefice, CFO, Restricted Stock Units, RSU Vesting, Tax Withholding, Executive Compensation